These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 8791947)

  • 1. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer.
    Lanza FL; Sontag SJ; Ciociola AA; Sykes DL; Heath A; McSorley DJ
    Helicobacter; 1998 Sep; 3(3):212-21. PubMed ID: 9731994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori.
    Axon AT; Ireland A; Smith MJ; Rooprams PD
    Aliment Pharmacol Ther; 1997 Feb; 11(1):81-7. PubMed ID: 9042977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
    Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
    Pozzato P; Zagari M; Cardelli A; Catalano FA; Giglio A; Lami F; Pilotto A; Scarpulla G; Spadaccini A; Susi D; Tosatto R; Olivieri A; Bazzoli F; Roda E
    Aliment Pharmacol Ther; 1998 May; 12(5):447-51. PubMed ID: 9663724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
    Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
    Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
    Paré P; Farley A; Romãozinho JM; Bardhan KD; French PC; Roberts PM
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1071-8. PubMed ID: 10468683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer.
    Dobrilla G; Di Matteo G; Dodero M; Fratton A; Iaquinto G; Loriga P; Marchi S; Marzio L; Muratori R; Pacini D; Saggioro A; Savarino V; Spinelli P; Zamboni G; Fina P; Tosatto R; Olivieri A
    Aliment Pharmacol Ther; 1998 Jan; 12(1):63-8. PubMed ID: 9692703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
    Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
    Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
    Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
    Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
    Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
    Bardhan KD; Dallaire C; Eisold H; Duggan AE
    Gut; 1997 Aug; 41(2):181-6. PubMed ID: 9301496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
    Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
    Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
    Spinzi GC; Boni F; Bortoli A; Colombo E; Ballardini G; Venturelli R; Minoli G
    Aliment Pharmacol Ther; 2000 Mar; 14(3):325-30. PubMed ID: 10735926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
    Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
    Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori.
    Schwartz HI; Perschy TB; McSorley DJ; Sorrells SC
    Helicobacter; 1999 Jun; 4(2):121-7. PubMed ID: 10382126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
    Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.